1. Correlation between sex and efficacy of immune checkpoint inhibitors (PD‐1 and CTLA‐4 inhibitors). Issue 1 (8th March 2018) Authors: Wu, Yingcheng; Ju, Qianqian; Jia, Keren; Yu, Jingyan; Shi, Hui; Wu, Huiqun; Jiang, Maorong Journal: International journal of cancer Issue: Volume 143:Issue 1(2018) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer. Issue 4 (31st March 2022) Authors: Zhang, Cheng; Chong, Xiaoyi; Jiang, Fangli; Gao, Jing; Chen, Yang; Jia, Keren; Fan, Meng; Liu, Xuan; An, Jin; Li, Jian; Zhang, Xiaotian; Shen, Lin Journal: Journal of extracellular vesicles Issue: Volume 11:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta‐analysis of efficacy and safety. Issue 12 (30th August 2017) Authors: Wu, Yingcheng; Shi, Hui; Jiang, Maorong; Qiu, Mingyan; Jia, Keren; Cao, Tianyue; Shang, Yujuan; Shi, Lili; Jiang, Kui; Wu, Huiqun Journal: International journal of cancer Issue: Volume 141:Issue 12(2017:Dec. 15) Page Start: 2562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗